Genetesis Added Significant Strategic Investor- TDK Ventures

Published on
April 21, 2020
TDK Ventures
Venture Capitalist Company

TDK Corporation (TSE: 6762) announces that subsidiary TDK Ventures Inc. adds to its growing portfolio of companies with an investment in Genetesis, a world leader in non-invasive biomagnetic imaging. Genetesis is the fifth investment by the TDK corporate venture capital (CVC) fund, and first in digital healthcare, since its July 2019 launch – with a mission to invest in innovative startups focusing on digital and energy transformation and contributing to sustainability.